1 completed, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Brain Edema: new trials by email Literature Review of Brain Edema trials Research Report on Brain Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage Fingolimod, Placebo, Open-label Fingolimod - Intracerebral Hemorrhage, Cerebral Edema | Early Phase 1 | Completed | Wake Forest University Health Sciences | 28 | 2020-08-07 | 2025-01-23 |
| Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation 3% Sodium Chloride, 23.4% Sodium Chloride, 8.4% Sodium Bicarbonate - Cerebral Edema, Saline Solution, Hypertonic | Early Phase 1 | Withdrawn | Stanford University | 2017-11-28 | 2020-03-19 |
Brain Injuries (1) · Cerebral Hemorrhage (1) · Hemorrhagic Stroke (1) · Intracranial Hemorrhage, Hypertensive (1) · Neurologic Manifestations (1) · Stroke (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Craniocerebral Trauma (1) · Hemorrhage (1) · Intracranial Hemorrhages (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Trauma, Nervous System (1) · Vascular Diseases (1) · Wounds and Injuries (1)
Fingolimod Hydrochloride (1) · Sodium Bicarbonate (1) · Sodium Chloride (1)
Stanford University (1) · Wake Forest University Health Sciences (1)
United States (2)
Stacey Q Wolfe, MD (1) · Tim Angelotti, MD, PhD (1)
UL1TR001420 (1)